Association of 2 SNPs with current and lifetime maximum BMI in control and case subjects.

<p>Association of 2 SNPs with current and lifetime maximum BMI in control and case subjects.</p

Clinical characteristics of the study subjects.

<p>Clinical characteristics of the study subjects.</p

Genotype, allele frequencies, and HWE of 2SNPs within <i>FTO</i> gene in the present population.

<p>Genotype, allele frequencies, and HWE of 2SNPs within <i>FTO</i> gene in the present population.</p

Association of the various aspects of BMI history with type 2 diabetes.

<p>Association of the various aspects of BMI history with type 2 diabetes.</p

Association results between 2 SNPs and type 2 diabetes.

<p>Association results between 2 SNPs and type 2 diabetes.</p

Comparison of the serum total adiponectin level between diabetic subjects treated with and without pioglitazone.

<p>Comparison of the serum total adiponectin level between diabetic subjects treated with and without pioglitazone.</p

Comparison of the various adiponectin-related parameters between diabetic subjects and control subjects in the 1^st group.

<p>Comparison of the various adiponectin-related parameters between diabetic subjects and control subjects in the 1^st group.</p

Odds ratios of adiponectin-related parameters for diabetes in the 1^st group.

<p>Odds ratios of adiponectin-related parameters for diabetes in the 1^st group.</p

Association of adiponectin-related parameters with HOMA-IR in the 2^nd group.

<p>Association of adiponectin-related parameters with HOMA-IR in the 2^nd group.</p

Selection of study subjects and analyses in the 1^st and 2^nd groups.

<p>HMW, high molecular weight; MMW, middle molecular weight; LMW, low molecular weight.</p